Drug development is an expensive and high-risk process. The median cost per approved drug can reach up to $2.8 billion, ...

Analytics Insight is a leading international platform for important analysis of artificial intelligence, big data, robotics, ...

Generative AI is a boardroom priority. 95% of organizations have AI on their leadership agenda, with more than half actively championing its adoption. Data challenges remain a major barrier. Nearly 70 ...

Report shows 80% feel genAI has met or exceeded expectations but insufficient training, lack of trust, and ethical considerations remain barriers to realizing its full valueNEW YORK, Feb. 11, 2025 ...

AWS CEO Matt Garman talks AI impacts in 2025, tech innovation investments in silicon, cloud, storage, GenAI, AWS partners and ...

The company added seven new clients and expanded 52 existing relationships, underscoring its growing AI-driven service portfolio.

a leading global provider of AI-powered analytics and decision tools, today released results from its second annual LexisNexis Future of Work Report, which demonstrates growing maturity and active ...